JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1997; 30:1506-1511
© 1997 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lanzarotti, C.
Right arrow Articles by Olshansky, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lanzarotti, C.
Right arrow Articles by Olshansky, B

Thromboembolism in chronic atrial flutter: is the risk underestimated?

CJ Lanzarotti and B Olshansky

Division of Cardiology, Loyola University Medical Center, Maywood, Illinois 60153, USA.

OBJECTIVES: We sought to evaluate the risk of thromboembolic events in the presence of chronic atrial flutter and to determine the impact of anticoagulation therapy, if any, on this risk. BACKGROUND: Thromboembolic events are thought to be rare after cardioversion of atrial flutter. METHODS: This study was a retrospective analysis of 110 consecutive patients referred to the electrophysiology laboratory for cardioversion of chronic atrial flutter from 1986 to 1996. Atrial flutter was present for at least 6 months. Of the 110 patients reviewed, 100 had adequate information available regarding the effectiveness of anticoagulation (mean age 64 years, range 27 to 86; 75 men, 25 women; mean left ventricular ejection fraction 42%). RESULTS: Thirteen patients (13%) had a thromboembolic event. Of these, seven were attributable to causes other than atrial flutter. In the remaining six patients (6%), thromboembolic events occurred during a rhythm of atrial flutter or after cardioversion to sinus rhythm. Other causes of thromboembolism were excluded. Effective anticoagulation was associated with a decreased risk of thromboembolism (p = 0.026). CONCLUSIONS: Patients with chronic atrial flutter are at an increased risk of thromboembolic events. Effective anticoagulation may decrease this risk.


This article has been cited by other articles:


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 546S - 592S.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. J. Blanc, J. Almendral, M. Brignole, M. Fatemi, K. Gjesdal, E. Gonzalez-Torrecilla, P. Kulakowski, G. Y.H. Lip, D. Shah, C. Wolpert, et al.
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures
Europace, May 1, 2008; 10(5): 513 - 527.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Doufekias, A. Z. Segal, and J. R. Kizer
Cardiogenic and aortogenic brain embolism.
J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1049 - 1059.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. D. Demir, M. Soylu, O. Ozdemir, S. Topaloglu, D. Aras, A. Iasmaz, and I. Korkmaz
Do Different Atrial Flutter Types Carry the Same Thromboembolic Risk?
Angiology, September 1, 2005; 56(5): 593 - 599.
[Abstract] [PDF]


Home page
EuropaceHome page
M. F. Scholten, A. S. Thornton, J. M. Mekel, P. J. Koudstaal, and L. J. Jordaens
Anticoagulation in atrial fibrillation and flutter
Europace, January 1, 2005; 7(5): 492 - 499.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 429S - 456S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Sakurai, T. Hirai, K. Nakagawa, T. Kameyama, T. Nozawa, H. Asanoi, and H. Inoue
Left Atrial Appendage Function and Abnormal Hypercoagulability in Patients With Atrial Flutter
Chest, November 1, 2003; 124(5): 1670 - 1674.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Olshansky
High intensity anticoagulation for cardioversion of atrial arrhythmias? The shocking truth
J. Am. Coll. Cardiol., September 4, 2002; 40(5): 934 - 936.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Schmidt, G. von der Recke, S. Illien, T. Lewalter, R. Schimpf, C. Wolpert, H. Becher, B. Luderitz, and H. Omran
Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 778 - 784.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. B. Sparks and J. M. Kalman
Is atrial flutter a risk factor for stroke?
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 785 - 788.
[Full Text] [PDF]


Home page
Eur Heart JHome page
G.Y.H. Lip and S. Kamath
Thromboprophylaxis for atrial flutter
Eur. Heart J., June 2, 2001; 22(12): 984 - 987.
[PDF]


Home page
Eur Heart JHome page
G Corrado, A Sgalambro, A Mantero, F Gentile, M Gasparini, R Bufalino, A Morabito, G Trocino, R Schiavina, S Mandorla, et al.
Thromboembolic risk in atrial flutter. The FLASIEC (FLutterAtrialeSocietaIaliana diEcografiaCardiovascolare) multicentre study
Eur. Heart J., June 2, 2001; 22(12): 1042 - 1051.
[Abstract] [PDF]


Home page
ChestHome page
G. W. Albers, J. E. Dalen, A. Laupacis, W. J. Manning, P. Petersen, and D. E. Singer
Antithrombotic Therapy in Atrial Fibrillation
Chest, January 1, 2001; 119(1_suppl): 194S - 206S.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C. Stellbrink and P. Hanrath
The optimal management of cardioversion of atrial fibrillation of flutter: still a 'stunning' problem
Eur. Heart J., May 2, 2000; 21(10): 795 - 798.
[PDF]


Home page
Eur Heart JHome page
A Roijer, J Eskilsson, and B Olsson
Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion
Eur. Heart J., May 2, 2000; 21(10): 837 - 847.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
P. B. Sparks, S. Jayaprakash, J. K. Vohra, H. G. Mond, A. G. Yapanis, L. E. Grigg, and J. M. Kalman
Left atrial "stunning" following radiofrequency catheter ablation of chronic atrial flutter
J. Am. Coll. Cardiol., August 1, 1998; 32(2): 468 - 475.
[Abstract] [Full Text] [PDF]


Home page
JWatch GeneralHome page
THROMBOEMBOLISM COMMON WITH CHRONIC ATRIAL FLUTTER
Journal Watch (General), November 14, 1997; 1997(1114): 7 - 7.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1997 by the American College of Cardiology Foundation.